Strontium-driven Physiological to Pathological Transition of Bone-like Architecture: A Dose-dependent Investigation
Overview
Authors
Affiliations
Whilst strontium (Sr) is widely investigated for treating osteoporosis, it is also related to mineralization disorders such as rickets and osteomalacia. In order to clarify the physiological and pathological effects of Sr on bone biomineralization , we performed a dose-dependent investigation in bone components using a 3D scaffold that displays the hallmark features of bone tissue in terms of composition (osteoblast, collagen, carbonated apatite) and architecture (mineralized collagen fibrils hierarchically assembled into a twisted plywood geometry). As the level of Sr is increased from physiological-like to excess, both the mineral and the collagen fibrils assembly are destabilized, leading to a drop in the Young modulus, with strong implications on pre-osteoblastic cell proliferation. Furthermore, the microstructural and mechanical changes reported here correlate with that observed in bone-weakening disorders induced by Sr accumulation, which may clarify the paradoxical effects of Sr in bone mineralization. More generally, our results provide physicochemical insights into the possible effects of inorganic ions on the assembly of bone extracellular matrix and may contribute to the design of safer therapies for treating osteoporosis. STATEMENT OF SIGNIFICANCE: Physiological-like (10% Sr) and excess accumulation-like (50% Sr) doses of Sr are investigated in 3D biomimetic assemblies possessing the high degree of organization found in the extracellular of bone. Above the physiological dose, the organic and inorganic components of the bone-like scaffold are destabilized, resulting in impaired cellular activity, which correlates with bone-weakening disorders induced by Sr.
Pimenta I, Chaves Filho G, Silva E, Nogueira L, de Mendonca T, Furtado T ACS Omega. 2025; 10(5):4836-4846.
PMID: 39959088 PMC: 11822716. DOI: 10.1021/acsomega.4c09949.
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.
Shariati K, Bedar M, Huang K, Moghadam S, Mirzaie S, LaGuardia J Adv Ther (Weinh). 2025; 8(1.
PMID: 39867107 PMC: 11756815. DOI: 10.1002/adtp.202400296.
Zhang Y, Chen Y, Shi Y, Hu H, Dai Z, Liu Z Front Cell Dev Biol. 2025; 12():1506671.
PMID: 39834391 PMC: 11743474. DOI: 10.3389/fcell.2024.1506671.